## EFX: Equifax, Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.05 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($200.27)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Equifax (EFX) Stock Performance 2025: Declines vs. Industrial Sector Benchmarks - News and Statistics**
- Source: IndexBox | 20251208T120827 | Neutral | Relevance: 99%
-  Equifax Inc. (EFX) stock has significantly underperformed the broader industrial sector benchmarks in 2025, with declines of 17% year-to-date and 18.9% over the past 52 weeks, contrasting sharply with the Industrial Select Sector SPDR Fund's (XLI) gains. Despite reporting better-than-expected Q3 financial results including a 7.2% year-over-year revenue growth and 10.3% increase in adjusted EPS, the stock experienced only a marginal dip initially before mild positive momentum. EFX also underperformed a peer like TransUnion (TRU).

**2. Equifax (NYSE:EFX) Given New $234.00 Price Target at BMO Capital Markets**
- Source: MarketBeat | 20251208T134608 | Neutral | Relevance: 99%
-  BMO Capital Markets has lowered its price target for Equifax (NYSE:EFX) to $234.00 from $245.00, while maintaining a "market perform" rating. Despite this, the stock holds a "Moderate Buy" consensus among analysts with an average price target of $276.40. Equifax recently exceeded Q3 earnings and revenue estimates and provided positive FY2025 guidance.

**3. Invesco Ltd. Reduces Stock Position in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251206T112647 | Neutral | Relevance: 99%
-  Invesco Ltd. reduced its stake in Equifax, Inc. by 10.4% in the second quarter, selling 187,288 shares and ending with 1,621,234 shares worth $420,499,000. Other institutional investors also adjusted their positions in Equifax. The article details Equifax's stock performance, recent earnings, dividend announcement, and analyst ratings, noting an average rating of "Moderate Buy" with a consensus price target of $277.13.

**4. Equifax, Inc. $EFX Shares Sold by Baird Financial Group Inc.**
- Source: MarketBeat | 20251206T060823 | Neutral | Relevance: 98%
-  Baird Financial Group Inc. reduced its stake in Equifax, Inc. by 6.8% in Q2 2025, selling 13,987 shares. Despite this, other major institutional investors like Vanguard, T. Rowe Associates, and Harris Associates significantly increased their holdings, leading to institutional ownership of 96.20%. Equifax also reported strong Q3 earnings, beating estimates and providing optimistic Q4 and full-year 2025 guidance, although insiders were net sellers of shares.

**5. Amundi Buys 23,161 Shares of Equifax, Inc. $EFX**
- Source: MarketBeat | 20251209T080808 | Neutral | Relevance: 98%
- Amundi has increased its stake in Equifax, Inc. (NYSE:EFX) by 11.2%, acquiring an additional 23,161 shares, bringing its total holdings to 230,283 shares valued at approximately $60.4 million. Several other institutional investors also adjusted their positions in the credit services provider during the second quarter. Meanwhile, company insiders, including CEO Mark W. Begor and EVP Jamil Farshchi, sold a significant number of shares, while Wall Street analysts provided a "Moderate Buy" consensus rating with a target price of $276.40.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 13.6% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.9B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 23.8 |
| Current P/E | 27.6 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -1.6% (minimal 5-day change). Below STRENGTH zone by 5.6pp (needs >4.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. MACD histogram positive (1.13), confirming momentum. RSI neutral at 45. Elevated volume (1.5x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.63% (CS: 43) | Neutral |
| RSI_14 | 45.0 | Neutral |
| MACD Histogram | 1.13 | Bullish |
| vs SMA20 | 1.004x | Above |
| vs SMA50 | 0.954x | Below |
| vs SMA200 | 0.864x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $210.29
- **Stop Loss:** $200.27 (4.8% risk)
- **Target:** $230.33 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 49
- **Position Value:** $10,304.21
- **Portfolio %:** 10.30%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*